Elderly Lung Disease Patients in UK Find 'Hospital at Home' Is Effective Alternative
Read about a report showing that 'hospital at home' represents a beneficial alternative to acute hospitalization for some lung disease patients.
Philips and Grand Challenges Canada Collaborate to Address Global Childhood Pneumonia - Lung Disease News
Read about the collaboration between Philips and Grand Challenges Canada to address global childhood pneumonia mortality.
Cempra Asks FDA to Approve Antibiotic to Treat Community-Acquired Bacterial Pneumonia - Lung Disease News
Read about Cempra's completing a new drug application to the FDA for solithromycin, an antibiotic developed to treat community-acquired bacterial pneumonia.
Rapid Diagnostic Test for Mycoplasma pneumoniae Receives EU Mark of Approval - Lung Disease News
Read about Meridian Bioscience's diagnostic test for the detection of Mycoplasma pneumoniae that received CE marking in the EU.
Oral Pneumonia Drug, Solithromycin, Shows Safety and Efficacy in Phase 3 Trial - Lung Disease News
Here, Phase 3 trial results found oral solithromycin of similar efficacy and safety to moxifloxacin in treating community-acquired bacterial pneumonia.
Promising Drug Candidate Tackles Wide Variety of Antibiotic-Resistant Infections - Lung Disease News
Read about TGV-Laboratories' novel promising drug, Mul-1867, to treat antibiotic-resistant fungal and bacterial infections.
NIH Grant to Advance Lung Therapeutics' Empyema Drug Therapy
Read about the NIH grant awarded to Lung Therapeutics' and UT Health Northeast to develop a treatment for located pleural effusion.
Study Shows Aradigm's Lipoquin and Pulmaquin As Promising Therapies for Treatment of Pulmonary NTM - Lung Disease News
0 (0) In a poster communication that will be presented on September 19, 2015 at the International Congress of Chemotherapy and Infection (ICAAC/ICC 2015) in San Diego, CA, entitled “Treatment of Lung Infection Caused by Mycobacterium abscessus in Beige Mice with Pulmonary Delivery of Liposomally Encapsulated Ciprofloxacin is Associated with Significant Reduction of Bacterial Load,” researchers from Oregon State […]